Board Meetings for JBCHEPHARM

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited06 Nov 2024Financial ResultsTo consider and approve the financial results for the period ended September 30, 2024
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited08 Aug 2024Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2024
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited08 Aug 2024JB CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 08-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 .Board Meeting Intimation
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited17 May 2024Financial Results/DividendTo consider and approve the audited financial results for the year and quarter ended March 31, 2024 and consideration and recommendation of dividend on equity shares of the Company, if any, subject to approval of shareholders
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited17 May 2024JB CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 17-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend.Board Meeting Intimation
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited06 Feb 2024JB CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 06-Feb-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2023 and Dividend.Board Meeting Intimation
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited06 Feb 2024Financial Results/DividendTo consider and approve the financial results for the period ended December 31, 2023 and dividend
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited07 Nov 2023Financial ResultsTo consider and approve the unaudited financial results for the quarter and half year ended on September 30, 2023
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited07 Nov 2023JB CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 .Board Meeting Intimation
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited09 Aug 2023Financial ResultsTo consider and approve the unaudited financial results for the quarter ended June 30, 2023
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited09 Aug 2023JB CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 09-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2023 .Board Meeting Intimation
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited24 May 2023Financial Results/DividendTo consider and approve audited financial results for the year and quarter ended on March 31, 2023, recommendation of final Dividend on equity shares of the Company, if any, and consideration and approval of the proposal to sub-divide/split the equity shares
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited24 May 2023Stock SplitTo consider and approve audited financial results for the year and quarter ended on March 31, 2023, recommendation of final Dividend on equity shares of the Company, if any, and consideration and approval of the proposal to sub-divide/split the equity shares
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited24 May 2023JB CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 24-May-2023 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2023 and Dividend/Stock split.Board Meeting Intimation
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited08 Feb 2023Financial Results/DividendTo consider and approve the (i) Unaudited financial results for the quarter ended on December 31, 2022; and (ii) Declaration of Interim dividend, if any, for the financial year 2022-23
Showing page 2 of 9 (122 total items)